Table 3.
Primary site, staging, time to recurrence, and treatment outcome of locoregional failures.
| Patient no. | Primary site | Stage | Site of failure | Time to failure detection, mon. | Salvage therapy | Clinical status |
|---|---|---|---|---|---|---|
| Locoregional recurrent disease | ||||||
|
| ||||||
| 1 | BOT | T2N2b | Local | 5 | Surgery | DOD |
| 2 | BOT | T3N2b | Local | 40 | Brachytherapy | Alive* |
| 3 | BOT | T1N2b | Regional | 11 | Chemotherapy | DOD |
| 4 | BOT | T2N2b | Regional | 26 | Surgery | Alive† |
DOD, died of disease
* No evidence of disease at 26 months after high-dose-rate brachytherapy and chemotherapy
† No evidence of disease at 25 months after neck dissection